Annual EBITDA
$8.88 B
-$3.25 B-26.78%
31 December 2023
Summary:
Abbott Laboratories annual earnings before interest, taxes, depreciation & amortization is currently $8.88 billion, with the most recent change of -$3.25 billion (-26.78%) on 31 December 2023. During the last 3 years, it has risen by +$41.00 million (+0.46%). ABT annual EBITDA is now -27.68% below its all-time high of $12.28 billion, reached on 31 December 2021.ABT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$2.46 B
-$91.00 M-3.57%
30 September 2024
Summary:
Abbott Laboratories quarterly earnings before interest, taxes, depreciation & amortization is currently $2.46 billion, with the most recent change of -$91.00 million (-3.57%) on 30 September 2024. Over the past year, it has dropped by -$200.00 million (-7.52%). ABT quarterly EBITDA is now -35.74% below its all-time high of $3.83 billion, reached on 31 March 2022.ABT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$10.16 B
-$200.00 M-1.93%
30 September 2024
Summary:
Abbott Laboratories TTM earnings before interest, taxes, depreciation & amortization is currently $10.16 billion, with the most recent change of -$200.00 million (-1.93%) on 30 September 2024. Over the past year, it has increased by +$104.00 million (+1.03%). ABT TTM EBITDA is now -27.15% below its all-time high of $13.95 billion, reached on 30 June 2022.ABT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.8% | -7.5% | +1.0% |
| 3 y3 years | +0.5% | -29.1% | -17.6% |
| 5 y5 years | +27.3% | +21.6% | +35.5% |
ABT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.7% | +0.5% | -35.7% | +7.9% | -27.1% | +1.0% |
| 5 y | 5 years | -27.7% | +27.3% | -35.7% | +65.7% | -27.1% | +39.8% |
| alltime | all time | -27.7% | +1002.9% | -35.7% | +191.0% | -27.1% | +806.7% |
Abbott Laboratories EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.46 B(-3.6%) | $10.16 B(-1.9%) |
| June 2024 | - | $2.55 B(+7.1%) | $10.36 B(-0.4%) |
| Mar 2024 | - | $2.38 B(-13.9%) | $10.40 B(-1.3%) |
| Dec 2023 | $8.88 B(-26.8%) | $2.77 B(+4.0%) | $10.54 B(+4.8%) |
| Sept 2023 | - | $2.66 B(+2.5%) | $10.06 B(-0.5%) |
| June 2023 | - | $2.60 B(+2.9%) | $10.11 B(-6.6%) |
| Mar 2023 | - | $2.52 B(+10.5%) | $10.82 B(-10.8%) |
| Dec 2022 | $12.13 B(-1.2%) | $2.28 B(-16.0%) | $12.13 B(-8.0%) |
| Sept 2022 | - | $2.71 B(-17.9%) | $13.19 B(-5.4%) |
| June 2022 | - | $3.31 B(-13.7%) | $13.95 B(+7.3%) |
| Mar 2022 | - | $3.83 B(+14.6%) | $13.00 B(+5.8%) |
| Dec 2021 | $12.28 B(+38.9%) | $3.34 B(-3.8%) | $12.28 B(-0.4%) |
| Sept 2021 | - | $3.47 B(+47.4%) | $12.33 B(+9.9%) |
| June 2021 | - | $2.36 B(-24.3%) | $11.22 B(+8.4%) |
| Mar 2021 | - | $3.11 B(-8.2%) | $10.35 B(+17.1%) |
| Dec 2020 | $8.84 B(+13.9%) | $3.39 B(+43.3%) | $8.84 B(+16.2%) |
| Sept 2020 | - | $2.37 B(+59.3%) | $7.61 B(+4.7%) |
| June 2020 | - | $1.49 B(-7.2%) | $7.27 B(-6.9%) |
| Mar 2020 | - | $1.60 B(-25.9%) | $7.80 B(+0.6%) |
| Dec 2019 | $7.76 B(+11.2%) | $2.16 B(+6.7%) | $7.76 B(+3.5%) |
| Sept 2019 | - | $2.02 B(+0.1%) | $7.50 B(+4.0%) |
| June 2019 | - | $2.02 B(+29.9%) | $7.21 B(+2.6%) |
| Mar 2019 | - | $1.56 B(-17.9%) | $7.02 B(+0.7%) |
| Dec 2018 | $6.98 B(+13.3%) | $1.90 B(+9.3%) | $6.98 B(+3.5%) |
| Sept 2018 | - | $1.73 B(-5.6%) | $6.74 B(+2.0%) |
| June 2018 | - | $1.84 B(+21.7%) | $6.61 B(+11.5%) |
| Mar 2018 | - | $1.51 B(-9.2%) | $5.93 B(-3.7%) |
| Dec 2017 | $6.16 B(+92.6%) | $1.66 B(+3.9%) | $6.16 B(+5.4%) |
| Sept 2017 | - | $1.60 B(+38.3%) | $5.84 B(+29.3%) |
| June 2017 | - | $1.16 B(-33.4%) | $4.52 B(-0.2%) |
| Mar 2017 | - | $1.74 B(+28.9%) | $4.53 B(+41.6%) |
| Dec 2016 | $3.20 B(-33.6%) | $1.35 B(+384.5%) | $3.20 B(+3.6%) |
| Sept 2016 | - | $278.00 M(-76.1%) | $3.09 B(-21.8%) |
| June 2016 | - | $1.17 B(+186.2%) | $3.95 B(-5.2%) |
| Mar 2016 | - | $407.00 M(-67.1%) | $4.16 B(-13.6%) |
| Dec 2015 | $4.82 B(+14.3%) | $1.24 B(+8.7%) | $4.82 B(-0.1%) |
| Sept 2015 | - | $1.14 B(-17.7%) | $4.82 B(+0.7%) |
| June 2015 | - | $1.38 B(+30.3%) | $4.79 B(+6.4%) |
| Mar 2015 | - | $1.06 B(-14.6%) | $4.50 B(+6.8%) |
| Dec 2014 | $4.22 B(+8.0%) | $1.24 B(+12.4%) | $4.22 B(+4.3%) |
| Sept 2014 | - | $1.10 B(+1.0%) | $4.04 B(+3.9%) |
| June 2014 | - | $1.09 B(+41.2%) | $3.89 B(+0.4%) |
| Mar 2014 | - | $775.00 M(-27.4%) | $3.87 B(-5.9%) |
| Dec 2013 | $3.90 B(+35.5%) | $1.07 B(+11.8%) | $4.11 B(+95.5%) |
| Sept 2013 | - | $954.00 M(-11.4%) | $2.10 B(-8.2%) |
| June 2013 | - | $1.08 B(+6.0%) | $2.29 B(-9.0%) |
| Mar 2013 | - | $1.02 B(-207.8%) | $2.52 B(-9.8%) |
| Dec 2012 | $2.88 B(-37.9%) | -$942.71 M(-182.5%) | $2.79 B(+19.9%) |
| Sept 2012 | - | $1.14 B(-12.4%) | $2.33 B(-12.1%) |
| June 2012 | - | $1.30 B(+1.2%) | $2.65 B(-33.2%) |
| Mar 2012 | - | $1.29 B(-191.7%) | $3.97 B(-14.5%) |
| Dec 2011 | $4.64 B(-47.8%) | -$1.41 B(-196.0%) | $4.64 B(-46.5%) |
| Sept 2011 | - | $1.46 B(-44.1%) | $8.67 B(-4.7%) |
| June 2011 | - | $2.62 B(+33.7%) | $9.10 B(+2.8%) |
| Mar 2011 | - | $1.96 B(-25.4%) | $8.85 B(-0.5%) |
| Dec 2010 | $8.89 B(-9.3%) | $2.63 B(+39.1%) | $8.89 B(+1.5%) |
| Sept 2010 | - | $1.89 B(-20.2%) | $8.76 B(-7.0%) |
| June 2010 | - | $2.37 B(+18.2%) | $9.41 B(+1.4%) |
| Mar 2010 | - | $2.00 B(-19.7%) | $9.29 B(-5.3%) |
| Dec 2009 | $9.80 B(+19.2%) | $2.49 B(-2.1%) | $9.80 B(-2.6%) |
| Sept 2009 | - | $2.55 B(+13.6%) | $10.07 B(+6.9%) |
| June 2009 | - | $2.24 B(-11.1%) | $9.42 B(+0.0%) |
| Mar 2009 | - | $2.52 B(-8.6%) | $9.41 B(+8.9%) |
| Dec 2008 | $8.22 B(+27.8%) | $2.76 B(+45.6%) | $8.65 B(+9.6%) |
| Sept 2008 | - | $1.90 B(-15.4%) | $7.89 B(+6.3%) |
| June 2008 | - | $2.24 B(+27.6%) | $7.43 B(+9.1%) |
| Mar 2008 | - | $1.76 B(-12.3%) | $6.81 B(+5.8%) |
| Dec 2007 | $6.43 B(+14.6%) | $2.00 B(+39.9%) | $6.43 B(+9.1%) |
| Sept 2007 | - | $1.43 B(-11.8%) | $5.90 B(+2.5%) |
| June 2007 | - | $1.62 B(+17.5%) | $5.75 B(+13.5%) |
| Mar 2007 | - | $1.38 B(-5.7%) | $5.07 B(-0.7%) |
| Dec 2006 | $5.61 B(-2.1%) | $1.46 B(+14.0%) | $5.10 B(-3.3%) |
| Sept 2006 | - | $1.28 B(+37.2%) | $5.27 B(+1.8%) |
| June 2006 | - | $936.39 M(-33.8%) | $5.18 B(-8.7%) |
| Mar 2006 | - | $1.42 B(-13.6%) | $5.67 B(-1.1%) |
| Dec 2005 | $5.74 B(+5.0%) | $1.64 B(+37.6%) | $5.74 B(+2.3%) |
| Sept 2005 | - | $1.19 B(-16.6%) | $5.61 B(-2.6%) |
| June 2005 | - | $1.43 B(-3.6%) | $5.76 B(+2.0%) |
| Mar 2005 | - | $1.48 B(-1.9%) | $5.65 B(+3.3%) |
| Dec 2004 | $5.47 B | $1.51 B(+12.4%) | $5.47 B(+2.6%) |
| Sept 2004 | - | $1.34 B(+2.3%) | $5.32 B(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $1.31 B(+1.1%) | $5.10 B(+18.5%) |
| Mar 2004 | - | $1.30 B(-5.0%) | $4.31 B(+0.1%) |
| Dec 2003 | $4.20 B(-2.4%) | $1.37 B(+22.2%) | $4.30 B(+19.6%) |
| Sept 2003 | - | $1.12 B(+116.2%) | $3.59 B(-2.3%) |
| June 2003 | - | $518.00 M(-59.9%) | $3.68 B(-13.0%) |
| Mar 2003 | - | $1.29 B(+95.1%) | $4.23 B(-1.7%) |
| Dec 2002 | $4.30 B(-2.0%) | $662.72 M(-45.0%) | $4.30 B(-10.7%) |
| Sept 2002 | - | $1.20 B(+12.8%) | $4.82 B(+3.3%) |
| June 2002 | - | $1.07 B(-21.9%) | $4.67 B(-0.3%) |
| Mar 2002 | - | $1.37 B(+16.2%) | $4.68 B(+6.5%) |
| Dec 2001 | $4.39 B(+3.9%) | $1.18 B(+11.8%) | $4.39 B(+1.3%) |
| Sept 2001 | - | $1.05 B(-2.7%) | $4.34 B(+1.8%) |
| June 2001 | - | $1.08 B(+0.0%) | $4.26 B(-0.5%) |
| Mar 2001 | - | $1.08 B(-3.6%) | $4.29 B(+1.4%) |
| Dec 2000 | $4.23 B(+6.3%) | $1.12 B(+14.7%) | $4.23 B(+2.3%) |
| Sept 2000 | - | $977.61 M(-11.5%) | $4.13 B(+4.6%) |
| June 2000 | - | $1.10 B(+7.9%) | $3.95 B(+1.7%) |
| Mar 2000 | - | $1.02 B(-0.3%) | $3.88 B(-2.4%) |
| Dec 1999 | $3.98 B(+1.9%) | $1.03 B(+29.2%) | $3.98 B(+0.0%) |
| Sept 1999 | - | $795.00 M(-23.4%) | $3.98 B(-2.6%) |
| June 1999 | - | $1.04 B(-7.1%) | $4.08 B(+1.4%) |
| Mar 1999 | - | $1.12 B(+8.8%) | $4.03 B(+3.2%) |
| Dec 1998 | $3.90 B(+9.6%) | $1.03 B(+13.9%) | $3.90 B(+2.1%) |
| Sept 1998 | - | $901.20 M(-8.3%) | $3.82 B(+2.2%) |
| June 1998 | - | $982.39 M(-1.1%) | $3.74 B(+2.7%) |
| Mar 1998 | - | $993.40 M(+5.0%) | $3.64 B(+2.3%) |
| Dec 1997 | $3.56 B(+7.9%) | $946.40 M(+15.4%) | $3.56 B(+1.5%) |
| Sept 1997 | - | $820.10 M(-7.3%) | $3.51 B(+1.6%) |
| June 1997 | - | $884.57 M(-3.0%) | $3.45 B(+2.3%) |
| Mar 1997 | - | $911.89 M(+2.0%) | $3.38 B(+2.2%) |
| Dec 1996 | $3.30 B(+12.0%) | $893.85 M(+17.1%) | $3.30 B(+2.2%) |
| Sept 1996 | - | $763.47 M(-5.5%) | $3.23 B(+2.6%) |
| June 1996 | - | $807.60 M(-3.7%) | $3.15 B(+2.9%) |
| Mar 1996 | - | $838.30 M(+1.9%) | $3.06 B(+3.8%) |
| Dec 1995 | $2.95 B(+11.1%) | $822.79 M(+20.6%) | $2.95 B(+4.0%) |
| Sept 1995 | - | $682.13 M(-5.0%) | $2.84 B(+2.4%) |
| June 1995 | - | $717.85 M(-1.2%) | $2.77 B(+1.7%) |
| Mar 1995 | - | $726.56 M(+2.5%) | $2.72 B(+2.5%) |
| Dec 1994 | $2.65 B(+10.2%) | $709.15 M(+15.4%) | $2.65 B(-0.5%) |
| Sept 1994 | - | $614.63 M(-8.5%) | $2.67 B(+1.7%) |
| June 1994 | - | $671.60 M(+1.9%) | $2.62 B(+4.8%) |
| Mar 1994 | - | $659.34 M(-8.7%) | $2.50 B(+3.9%) |
| Dec 1993 | $2.41 B(+23.2%) | $721.85 M(+26.7%) | $2.41 B(+7.0%) |
| Sept 1993 | - | $569.90 M(+3.3%) | $2.25 B(+0.7%) |
| June 1993 | - | $551.50 M(-2.4%) | $2.24 B(+12.2%) |
| Mar 1993 | - | $564.80 M(0.0%) | $1.99 B(+2.0%) |
| Dec 1992 | $1.95 B(+0.9%) | $564.80 M(+1.8%) | $1.95 B(+0.6%) |
| Sept 1992 | - | $554.70 M(+79.9%) | $1.94 B(+5.9%) |
| June 1992 | - | $308.30 M(-41.4%) | $1.83 B(-8.0%) |
| Mar 1992 | - | $526.10 M(-4.9%) | $1.99 B(+3.0%) |
| Dec 1991 | $1.94 B(+9.9%) | $553.30 M(+23.8%) | $1.94 B(+3.0%) |
| Sept 1991 | - | $446.80 M(-4.4%) | $1.88 B(+2.1%) |
| June 1991 | - | $467.50 M(-0.2%) | $1.84 B(+1.5%) |
| Mar 1991 | - | $468.40 M(-5.7%) | $1.81 B(+2.9%) |
| Dec 1990 | $1.76 B(+15.3%) | $496.90 M(+21.6%) | $1.76 B(-222.5%) |
| Sept 1990 | - | $408.80 M(-7.1%) | -$1.44 B(+168.1%) |
| June 1990 | - | $439.90 M(+5.6%) | -$536.40 M(-256.8%) |
| Mar 1990 | - | $416.50 M(-115.4%) | $342.20 M(-72.0%) |
| Dec 1989 | $1.53 B(+11.3%) | -$2.70 B(-306.3%) | $1.22 B(-12.5%) |
| Sept 1989 | - | $1.31 B(-0.6%) | $1.40 B(+7.5%) |
| June 1989 | - | $1.32 B(+1.8%) | $1.30 B(+7.3%) |
| Mar 1989 | - | $1.30 B(-151.2%) | $1.21 B(+9.7%) |
| Dec 1988 | $1.37 B(+9.9%) | -$2.53 B(-308.6%) | $1.10 B(-25.7%) |
| Sept 1988 | - | $1.21 B(-1.4%) | $1.48 B(+8.9%) |
| June 1988 | - | $1.23 B(+3.5%) | $1.36 B(+14.3%) |
| Mar 1988 | - | $1.19 B(-155.3%) | $1.19 B(+18.4%) |
| Dec 1987 | $1.25 B(+15.9%) | -$2.15 B(-297.0%) | $1.01 B(-21.9%) |
| Sept 1987 | - | $1.09 B(+2.9%) | $1.29 B(+13.2%) |
| June 1987 | - | $1.06 B(+5.5%) | $1.14 B(+11.9%) |
| Mar 1987 | - | $1.00 B(-153.8%) | $1.02 B(+15.7%) |
| Dec 1986 | $1.08 B(+20.7%) | -$1.87 B(-298.3%) | $878.60 M(-18.3%) |
| Sept 1986 | - | $940.90 M(+0.3%) | $1.08 B(+12.3%) |
| June 1986 | - | $938.00 M(+8.4%) | $957.40 M(+13.1%) |
| Mar 1986 | - | $865.50 M(-151.9%) | $846.40 M(+14.8%) |
| Dec 1985 | $892.90 M(+10.9%) | -$1.67 B(-302.8%) | $737.10 M(-11.1%) |
| Sept 1985 | - | $822.70 M(-0.5%) | $828.90 M(+12.4%) |
| June 1985 | - | $827.00 M(+9.4%) | $737.40 M(+3.6%) |
| Mar 1985 | - | $756.20 M(-148.0%) | $711.80 M(+5.2%) |
| Dec 1984 | $805.30 M | -$1.58 B(-315.7%) | $676.70 M(-70.0%) |
| Sept 1984 | - | $731.20 M(-8.8%) | $2.25 B(+48.0%) |
| June 1984 | - | $801.40 M(+11.1%) | $1.52 B(+111.1%) |
| Mar 1984 | - | $721.10 M | $721.10 M |
FAQ
- What is Abbott Laboratories annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Abbott Laboratories?
- What is Abbott Laboratories annual EBITDA year-on-year change?
- What is Abbott Laboratories quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Abbott Laboratories?
- What is Abbott Laboratories quarterly EBITDA year-on-year change?
- What is Abbott Laboratories TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Abbott Laboratories?
- What is Abbott Laboratories TTM EBITDA year-on-year change?
What is Abbott Laboratories annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ABT is $8.88 B
What is the all time high annual EBITDA for Abbott Laboratories?
Abbott Laboratories all-time high annual earnings before interest, taxes, depreciation & amortization is $12.28 B
What is Abbott Laboratories annual EBITDA year-on-year change?
Over the past year, ABT annual earnings before interest, taxes, depreciation & amortization has changed by -$3.25 B (-26.78%)
What is Abbott Laboratories quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ABT is $2.46 B
What is the all time high quarterly EBITDA for Abbott Laboratories?
Abbott Laboratories all-time high quarterly earnings before interest, taxes, depreciation & amortization is $3.83 B
What is Abbott Laboratories quarterly EBITDA year-on-year change?
Over the past year, ABT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$200.00 M (-7.52%)
What is Abbott Laboratories TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ABT is $10.16 B
What is the all time high TTM EBITDA for Abbott Laboratories?
Abbott Laboratories all-time high TTM earnings before interest, taxes, depreciation & amortization is $13.95 B
What is Abbott Laboratories TTM EBITDA year-on-year change?
Over the past year, ABT TTM earnings before interest, taxes, depreciation & amortization has changed by +$104.00 M (+1.03%)